SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response: 0.5

1. Name and Address of Reporting Person* VNV Global AB (publ) (Last) (First) (Middle) M?STER SAMUELSGATAN 1 (Street) STOCKHOLM V7 111 44 (City) (State) (Zip)	2. Date of Event Requiring Statement (Month/Day/Year) 12/30/2022	3. Issuer Name and Ticker or Trading Symbol Babylon Holdings Ltd [ BBLN ]
		4. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director X 10% Owner Officer (give title below) Other (specify below)	5. If Amendment, Date of Original Filed (Month/Day/Year)
			6. Individual or Joint/Group Filing (Check Applicable Line) Form filed by One Reporting Person X Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Class A ordinary shares	3,324,819	I	See footnote(1)
Class A ordinary shares	709,812	I	See footnote(2)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

1. Name and Address of Reporting Person* VNV Global AB (publ) (Last) (First) (Middle) M?STER SAMUELSGATAN 1 (Street) STOCKHOLM V7 111 44 (City) (State) (Zip)

1. Name and Address of Reporting Person* VNV (Cyprus) Ltd (Last) (First) (Middle) 1, LAMPOUSAS STREET (Street) NICOSIA G4 1095 (City) (State) (Zip)

Explanation of Responses:

1. These Class A ordinary shares (the "Shares") are owned directly by VNV (Cyprus) Limited ("VNV Cyprus"). VNV Cyprus is a wholly-owned subsidiary of VNV Global AB (publ) ("VNV Global"). VNV Global may be deemed to beneficially own the Shares held by VNV Cyprus.

2. These Shares are owned directly by Global Health Equity (Cyprus) Ltd ("Global Health Equity"). VNV Global indirectly holds, through its direct wholly-owned subsidiary, VNV Sweden AB ("VNV Sweden"), approximately 37.3521% of the shares in Global Health Equity AB (publ) ("Global Health (publ)"), the direct and sole shareholder of Global Health Equity, with the remainder held by other foreign institutional investors and individuals. VNV Global may be deemed to beneficially own the Shares held by Global Health Equity.

Remarks:

	/s/ Per Brilioth, Managing Director for VNV Global AB (publ)	12/30/2022
	/s/ Chrystalla Dekatris, Director of VNV (Cyprus) Limited	12/30/2022
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.